Skip to main content

3 Result(s)

within U. Räth Remove this filter Hematology Remove this filter

and

  1. No Access

    Article

    Comparison of 5 vs 10 μg/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer

    Despite the increasing use of granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of chemotherapy-induced neutropenia, few studies have focused on the activity and toxicity of the diffe...

    C. Bokemeyer, H. -J. Schmoll, B. Metzner, J. Beyer, H. J. Illiger… in Annals of Hematology (1993)

  2. No Access

    Article

    Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinoma

    In order to develop a more dose-intensive induction regimen for the treatment of far-advanced testicular tumours, the German Cooperative Group for Testicular Tumours started a dose-escalation trial of cisplati...

    A. Harstrick, H. -J. Schmoll, C. Bokemeyer… in Journal of Cancer Research and Clinical On… (1991)

  3. No Access

    Article

    Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha

    For palliative therapy during the chronic phase of CML busulfan has proved to be the drug of choice. During the past years hydroxyurea and also interferon-alpha have gained increasing significance since they m...

    R. Hehlmann, B. Anger, D. Messerer, R. Zankovich, L. Bergmann, H. J. Kolb, P. Meyer… in Blut (1988)